← Issue №18/ week of Nov 1, 2026/Hepatology

Low-dose versus standard dose of soybean-based intravenous lipid emulsions in neonates: A systematic review and meta-analysis.

From GI Signals issue №18: what this paper found, what it changes, and where it sits against the current standard of care, reviewed by Simon Mathews, MD.

Hepatology meta analysis · n=634 · Oct 27, 2026 · JPEN · IF 3.2

Low-dose versus standard dose of soybean-based intravenous lipid emulsions in neonates: A systematic review and meta-analysis.

New evidencesystematic reviewmeta-analysispediatricparenteral nutrition
Clinical takeawayNo clinical action yet: this meta-analysis found no difference in outcomes between low-dose (1 g/kg/day) and standard-dose (2-3 g/kg/day) SO-ILE in neonates, so current dosing practices remain unchanged.
What it foundLow-dose (1 g/kg/day) and standard-dose (2-3 g/kg/day) SO-ILE showed no significant differences in PNAC (53.4% vs. 48.5%), mortality (5.7% vs. 6.2%), or growth outcomes in neonates.
ContextConfirms current practice: prior evidence suggested lipid restriction might reduce PNAC risk, but this meta-analysis found no benefit to low-dose SO-ILE in neonates.
No standard claimed for this paper

Every paper is compared to the standard governing its question. This one is not: either no standard in the corpus matches it, or the comparison did not hold up on review and was withdrawn rather than published unverified. Both are logged.

Lima NA … Butler MW · JPEN. Journal of Parenteral and Enteral Nutrition · IF 3.2 · PubMed ↗Permalink
← Read the whole of issue №18 Every paper GI Signals surfaces gets a page like this one. All issues